Category: News

In the race to find new ways to prevent and treat COVID-19, BioCanRx and its partners, have launched an innovative clinical trial focused on strengthening the immune system for one of the most vulnerable populations – cancer patients.   The trial involves IMM-101, a preparation of safe, heat-killed bacteria that broadly stimulates the innate, or… Read more »

BioCanRx has partnered with the Ontario Institute for Cancer Research (OICR) and several other groups to provide funding and support for two new Clinical, Social, and Economic Impact (CSEI) projects led by Drs. Kelvin Chan and Kednapa Thavorn.   The objective of the CSEI Program is to develop potential solutions to social, legal, ethical, economic… Read more »

BioCanRx is happy to introduce the 13 undergraduate students chosen from across Canada through a competitive application process to be part of our Summer Studentship Program. The program’s goal is to inspire the next generation of highly qualified personnel to pursue research in cancer immuno-oncology. Undergraduate and college students receive funding to conduct research with… Read more »

  After careful consideration, BioCanRx has decided to postpone the 2020 Summit for Cancer Immunotherapy (Summit4CI) in light of the ongoing effects of the global COVID-19 pandemic. The 5th annual Summit4CI was scheduled to be held November 7-9, 2020, in Montréal, Québec. The Summit will still take place in Montréal, but the new dates will… Read more »

  BioCanRx Scientific Director Dr. John Bell was recently featured on CBC Radio’s Ottawa Morning program, speaking to host Robyn Bresnahan about the capabilities of cancer-fighting viruses to fight off COVID-19.   Listen here: https://www.cbc.ca/listen/live-radio/1-100-ottawa-morning/clip/15773851-covid-19-vaccine-research-grant Read more: https://www.cbc.ca/news/canada/ottawa/covid-19-cancer-therapeutics-ottawa-research-vaccine-trojan-horse-shopify-1.5550411

  BioCanRx Scientific Director Dr. John Bell and network investigator Dr. Carolina Ilkow are using their work in cancer immunotherapy at the Ottawa Hospital Research Institute to help pioneer a vaccine for COVID-19.   Ilkow, Bell and their research teams are using every tool in their immunotherapy arsenal to try to provoke an immune response… Read more »

Alan Neal of CBC/Radio-Canada spoke with The Ottawa Hospital’s Dr. Jean-Simon Diallo, a BioCanRx network investigator, about his research work during the COVID19 pandemic. His team is working on improving the way viruses grow in cells so they can help to produce vaccines more efficiently. Although viruses can sometimes be helpful in vaccines and curative… Read more »

  Scientists at The Ottawa Hospital have joined the global race to prevent and treat COVID-19 with many research projects in partnership with other scientists in Canada and around the world. Dr. Carolina Ilkow, a BioCanRx network investigator, spoke with the Ottawa Citizen about her project:   Read more: https://ottawacitizen.com/news/local-news/ottawa-hospital-researchers-join-the-global-race-to-treat-prevent-covid-19/

  Researchers at The Ottawa Hospital are ramping up research on possible COVID-19 treatments, vaccines and more. Among them are BioCanRx Scientific Director, Dr. John Bell, and network investigators Drs. Jean-Simon Diallo, Dean Fergusson, Carolina Ilkow and Manoj Lalu.   Read more from The Ottawa Hospital Research Institute

Dr. Karen Mossman, a researcher at McMaster University and also a BioCanRx network investigator, talks about how she and her team work with viruses and how they apply these strategies during the COVID-19 epidemic.   Read more from The Conversation.com